Although most complement research has focused on innate glial responses, the expression of C3aR on T cells and its role in modulating their phenotype and function—particularly in the post-acute phase—suggests a broader immunological role for complement signaling in stroke pathology [76]. This evidence concerns the gene C3AR1 and stroke disorder.